Evaxion A (EVAX) Non-Current Deferred Tax Liability (2022 - 2025)
Evaxion A (EVAX) posted Non-Current Deferred Tax Liability of $156000.0 for Q4 2025, up 19.08% on a QoQ basis from $131000.0 in Q4 2024, and up 19.08% year-over-year from $131000.0 in Q4 2024.
Evaxion A (EVAX) Non-Current Deferred Tax Liability (2022 - 2025) Analysis & Trends
Evaxion A's Non-Current Deferred Tax Liability history runs 4 years deep, the most recent figure standing at $156000.0 for Q4 2025.
- Quarterly Non-Current Deferred Tax Liability rose 19.08% year-over-year to $156000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $156000.0 (up 19.08% YoY) and the FY2025 annual result came in at $156000.0, up 19.08% from the prior year.
- Non-Current Deferred Tax Liability was $156000.0 for Q4 2025 at Evaxion A, up from $131000.0 in the prior quarter.
- Across five years, Non-Current Deferred Tax Liability topped out at $214000.0 in Q4 2022 and bottomed at $126000.0 in Q4 2023.
- A 4-year average of $156750.0 and a median of $143500.0 in 2024 frame the typical range for Non-Current Deferred Tax Liability.
- Annual changes were most pronounced in 2023 — Non-Current Deferred Tax Liability sank 41.12% — and 2025, when it rose 19.08%.
- Evaxion A's Non-Current Deferred Tax Liability stood at $214000.0 in 2022, then plunged by 41.12% to $126000.0 in 2023, then grew by 3.97% to $131000.0 in 2024, then advanced by 19.08% to $156000.0 in 2025.
- Business Quant data shows EVAX's Non-Current Deferred Tax Liability at $156000.0 in Q4 2025, $131000.0 in Q4 2024, and $126000.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Evaxion A | 1.23 Bn | 1.23 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 156,000.00 |
| Dec 31, 2025 | 156,000.00 |
| Dec 31, 2024 | 131,000.00 |
| Dec 31, 2024 | 131,000.00 |
| Dec 31, 2023 | 126,000.00 |
| Dec 31, 2023 | 126,000.00 |
| Dec 31, 2022 | 214,000.00 |
| Dec 31, 2022 | 214,000.00 |